SCHEMBL24310395

SCHEMBL24310395

Cc1cc(Oc2cc(-c3c(C)cccc3C)nc(NSc3cnn(C)c3)n2)ccc1N1CCNCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR3A P46098 4/20 0.39
▸ HTR3E A5X5Y0 1/20 0.39
▸ HTR3B O95264 1/20 0.39
▸ HTR3D Q70Z44 1/20 0.39
▸ HTR3C Q8WXA8 1/20 0.39
▸ ACVR1 Q04771 1/20 0.33
▸ HTR1A P08908 3/20 0.33
▸ HTR7 P34969 3/20 0.33
▸ HTR2B P41595 3/20 0.33
▸ PIM1 P11309 2/20 0.33
▸ PIM3 Q86V86 2/20 0.33
▸ PIM2 Q9P1W9 2/20 0.33
▸ HTR2A P28223 2/20 0.33
▸ HTR2C P28335 2/20 0.33
▸ HTR6 P50406 2/20 0.33
▸ ADRB1 P08588 2/20 0.32
▸ KCNH2 Q12809 1/20 0.31
▸ WEE1 P30291 2/20 0.30
▸ IRAK4 Q9NWZ3 1/20 0.30
▸ HTR1D P28221 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309350 0.94 HTR3A (0.33) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL24310587 0.90 FLT3 (0.37) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL24309516 0.84 FLT3 (0.35) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL29566284 0.83 HTR3E (0.39) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL26808265 0.83 HTR3E (0.39) HTR3AHTR3EHTR3BHTR3DHTR3C
SCHEMBL24309954 0.83 HTR1D (0.36) HTR1AHTR7HTR2AHTR6HTR1D
SCHEMBL24310555 0.83 BTK (0.35) PIM1PIM3PIM2
SCHEMBL24309872 0.83 CCNA2 (0.40) PIM1
SCHEMBL24310347 0.83 GPR39 (0.39) WEE1
SCHEMBL24310563 0.82 HPGD (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback